Article
Human BioSystems (HBS), a Palo Alto, Calif., biomedical company conducting research to extend the shelf life of blood platelets and donor organs, announced that it finalized a purchase agreement to acquire all rights to a skin-cream product previously developed for severe burns.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.